These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22082127)

  • 1. Th17-related cytokines: new players in the control of chronic intestinal inflammation.
    Monteleone I; Pallone F; Monteleone G
    BMC Med; 2011 Nov; 9():122. PubMed ID: 22082127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23 and Th17 cells in the control of gut inflammation.
    Monteleone I; Pallone F; Monteleone G
    Mediators Inflamm; 2009; 2009():297645. PubMed ID: 19503799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients.
    Bsat M; Chapuy L; Rubio M; Wassef R; Richard C; Schwenter F; Loungnarath R; Soucy G; Mehta H; Sarfati M
    Front Immunol; 2019; 10():1177. PubMed ID: 31191543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.
    Jiang W; Su J; Zhang X; Cheng X; Zhou J; Shi R; Zhang H
    Inflamm Res; 2014 Nov; 63(11):943-50. PubMed ID: 25129403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Th17 Cells in the Pathogenesis of Human IBD.
    Gálvez J
    ISRN Inflamm; 2014; 2014():928461. PubMed ID: 25101191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression of peripheral Th1 and Th17 cells in inflammatory bowel disease and its potential clinical value].
    Dai J; Zhang GB; Gao N; Xi QH; Li YQ; Pang Z; Zhao Y; Zhao JM; Nie JS; Chen WC
    Zhonghua Nei Ke Za Zhi; 2013 May; 52(5):375-8. PubMed ID: 23945300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 (IL-21) controls inflammatory pathways in the gut.
    Fina D; Caruso R; Pallone F; Monteleone G
    Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):288-91. PubMed ID: 18220949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen.
    Jyonouchi H; Geng L; Cushing-Ruby A; Monteiro IM
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e747-55. PubMed ID: 19725895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.
    Raza A; Yousaf W; Giannella R; Shata MT
    Expert Rev Clin Immunol; 2012 Feb; 8(2):161-8. PubMed ID: 22288454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Elshal MF; Aldahlawi AM; Saadah OI; Mccoy JP
    Clin Lab; 2016 Aug; 62(8):1521-1529. PubMed ID: 28164626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23/IL-17 axis in IBD.
    Sarra M; Pallone F; Macdonald TT; Monteleone G
    Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.